Cisplatin versus non-cisplatin based first-line chemotherapy for advanced urothelial carcinoma previously treated with peri-operative cisplatin

INTRODUCTION: The optimal choice of first-line chemotherapy in urothelial carcinoma (UC) patients who relapse after receiving peri-operative cisplatin-based chemotherapy (PCBC) is unclear. We investigated outcomes with cisplatin re-challenge vs. a non-cisplatin regimen in patients with recurrent met...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Genitourin Cancer
Autors principals: Locke, Jennifer A, Pond, Gregory Russell, Sonpavde, Guru, Necchi, Andrea, Giannatempo, Patrizia, Paluri, Ravi Kumar, Niegisch, Guenter, Albers, Peter, Buonerba, Carlo, di Lorenzo, Giuseppe, Vaishampayan, Ulka N., North, Scott A., Agarwal, Neeraj, Hussain, Syed A., Eigl, Bernhard J.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913522/
https://ncbi.nlm.nih.gov/pubmed/26589729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2015.10.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars